SVS Guidelines Bundle

Chronic Limb-Threatening Ischemia

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1309717

Contents of this Issue

Navigation

Page 20 of 23

21 Summary of Recommendations Recommendation Grade/ LOE 7.4 Do NOT offer prostanoids for limb salvage in CLTI patients. Consider offering selectively for patients with rest pain or minor tissue loss and in whom revascularization is not possible. 2-B 7.5 Do NOT offer vasoactive drugs or defibrinating agents (ancrod) in patients in whom revascularization is not possible. 1-C 7.6 Do NOT offer HBOT to improve limb salvage in CLTI patients with ischemic ulcers in whom revascularization is not possible. 1-A 7.7 Continue to provide optimal wound care until the lower extremity wound is completely healed or the patient undergoes amputation. GPS 8. Biologic and regenerative medicine approaches in CLTI 8.1 Restrict use of therapeutic angiogenesis to CLTI patients who are enrolled in a registered clinical trial. 1-B 9. e role of minor and major amputations 9.1 Consider transmetatarsal amputation of the forefoot in CLTI patients who would require more than two digital ray amputations to resolve distal necrosis, especially when the hallux is involved. 2-C 9.2 Offer primary amputation to CLTI patients who have a pre-existing dysfunctional or unsalvageable limb, a poor functional status (eg, bedridden), or a short life expectancy aer shared decision-making with the patient and health care team. 1-C 9.3 Consider secondary amputation for patients with CLTI who have a failed or ineffective reconstruction and in whom no further revascularization is possible and who have incapacitating pain, nonhealing wounds, or uncontrolled sepsis in the affected limb aer shared decision-making with the patient and health care team. 2-C 9.4 Consider revascularization to improve the possibility of healing an amputation at a more distal functional amputation level (eg, AKA to BKA), particularly for patients with a high likelihood of rehabilitation and continued ambulation. 2-C 9.5 Consider a TKA or AKA in patients who are nonambulatory for reasons other than CLTI (ie, bedridden patients with flexion contracture, dense hemiplegia, cancer) and are unlikely to undergo successful rehabilitation to ambulation. 2-C

Articles in this issue

Archives of this issue

view archives of SVS Guidelines Bundle - Chronic Limb-Threatening Ischemia